REVIEW PAPER
Periodontitis as a reservoir of human papillomavirus in the causation of oral squamous cell carcinoma: a review
More details
Hide details
1
Department of Periodontics, Manipal College of Dental Sciences, Mangalore at Manipal Academy of Higher Education, Karnataka, India
Submission date: 2019-07-06
Acceptance date: 2019-08-04
Publication date: 2020-06-28
HIV & AIDS Review 2020;19(2):74-77
KEYWORDS
TOPICS
ABSTRACT
Human papillomavirus (HPV) is a DNA virus from Papillomavirus family, and is one of the most widely reported sexual infection, which is not only related to ano-genital malignancies, but also associated with head and neck cancers, with chronic periodontitis being one of the risk factor for the same. Chronic periodontitis leads to loss of tissue structures of and around periodontium and is clinically detectable in the form of periodontal pocket and loss of alveolar bone. A variety of other systemic diseases have also been found to be linked to chronic periodontitis, such as cardiovascular diseases, respiratory diseases, etc., and recent data show that it is also related to malignancies of oral cavity. Junctional epithelium of periodontal pocket helps HPV to survive by facilitating the cellular functions to grow and hence, acts as a reservoir for the virus. Porphyromonas gingivalis, a Gram-negative anaero¬bic bacteria and HPV interacts both directly and indirectly in a series of complex reactions and as a result of some inflammatory reactions, this association further leads to commencement and progression of head and neck squamous cell carcinoma or oral squamous cell carcinoma. This article reviews the pathophysiology of oral human papillomavirus infection and its role in head and neck cancers, with chronic periodontitis as one of the causative factors.
REFERENCES (33)
1.
Suarez TP, Kelly JA, Pinkerton SD, et al. Influence of a partner’s HIV serostatus, use of highly active antiretroviral therapy, and viral load on perceptions of sexual risk behavior in a community sample of men who have sex with men. J Acquir Immune Defic Syndr 2001; 28: 471-477.
2.
Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
3.
Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-4301.
4.
Nielsen FL (ed.). Progress in Oral Cancer Research. New York: Nova Medical Books; 2008. p. 98.
5.
Kim SM. Human papillomavirus in oral cancer. J Korean Assoc Oral Maxillofac Surg 2016; 42: 327-336.
6.
Loesche WJ, Grossman NS. Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 2001; 14: 727-752.
7.
Tezal M, Nasca MS, Stoler DL, et al. Chronic periodontitis – human papillomavirus synergy in base of tongue cancers. Arch Otolaryngol Head Neck Surg 2009; 135: 391-396.
8.
Burt B; Research, Science and Therapy Committee of the American Academy of Periodontology. Position paper: epidemiology of periodontal diseases. J Periodontol 2005; 76: 1406-1419.
9.
Tezal M. Interaction between chronic inflammation and oral HPV infection in the etiology of head and neck cancers. Int J Otolaryngol 2012; 2012: 575242.
10.
Tezal M, Sullivan MA, Hyland A, et al. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2009; 18: 2406-2412.
11.
Lax AJ, Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol 2002; 10: 293-299.
12.
Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006; 124: 823-835.
13.
Huycke MM, Gaskin HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med 2004; 229: 586-597.
14.
Homann N, Tillonen J, Rintamäki H, Salaspuro M, Lindqvist C, Meurman JH. Poor dental status increases acetaldehyde production from ethanol in saliva: a possible link to increased oral cancer risk among heavy drinkers. Oral Oncol 2001; 37: 153-158.
15.
Visapää JP, Götte K, Benesovaetal M. Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C*1 allele, possibly due to salivary acetaldehyde. Gut 2004; 53: 871-876.
16.
Salaspuro MP. Acetaldehyde, microbes, and cancer of the digestive tract. Crit Rev Clin Lab Sci 2003; 40: 183-208.
17.
Shapiro KP, Hotchkiss JH, Roe DA. Quantitative relationship between oral nitrate-reducing activity and the endogenous formation of N-nitrosoamino acids in humans. Food Chem Toxicol 1991; 29: 751-755.
18.
Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 1995; 93: 17-48.
19.
Rüegg C. Leukocytes, inflammation and angiogenesis in cancer: fatal attractions. J Leukoc Biol 2006; 80: 682-684.
20.
Asting AG, Carén H, Andersson M, Lönnroth C, Lagerstedt K, Lundholm K. COX2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status. BMC Cancer 2011; 11: 238.
21.
Grivennikov SI, Karin M. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 2011; 70 Suppl 1: i104-i108.
22.
Tatemichi M, Ogura T, Esumi H. Impact of inducible nitric oxide synthase gene on tumor progression. Eur J Cancer Prev 2009; 18: 1-8.
23.
Allen C, Duffy S, Teknosetal T. Nuclear factor-kappaB-related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma. Clin Cancer Res 2007; 13: 3182-3190.
24.
Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-296.
25.
Wang D, Wang H, Shi Q, et al. Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell 2004; 6: 285-295.
26.
Stetler-Stevenson WG. The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2. Cancer Metastasis Rev 2008; 27: 57-66.
27.
Leaner VD, Donninger H, Birrer MJ. Transcription factors as targets for cancer therapy: AP-1 a potential therapeutic target. Curr Cancer Ther Rev 2007; 3: 1-6.
28.
Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004; 6: 447-458.
29.
Dauer DJ, Ferraro B, Songetal L. Stat3 regulates genes common to both wound healing and cancer. Oncogene 2005; 24: 3397-3408.
30.
Cassatella MA, Huber V, Calzetti F, et al. Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators. J Leukoc Biol 2006; 79: 123-132.
31.
Williams DA. Inflammatory cytokines and mucosal injury. J Natl Cancer Inst Monogr 2001; 29: 26-30.
32.
Pöllänen MT, Salonen JI, Uitto VJ. Structure and function of the tooth-epithelial interface in health and disease. Periodontology 2000; 31: 12-31.
33.
Han YW, Houcken W, Loos BG, Schenkein HA, Tezal M. Periodontal disease, atherosclerosis, adverse pregnancy outcomes, and head-and-neck cancer. Adv Dent Res 2014; 26: 47-55.